Photo of Martin P. Schrama

Martin P. Schrama is an expert Civil Trial Attorney as certified by the Supreme Court of New Jersey. He is also the Chair and Co-Founder of the Stark & Stark Mass Tort Litigation practice, as well as a member of the firm’s Commercial Litigation and Intellectual Property practices.

The Product – Elmiron

Elmiron, also known as pentosan polysulfate sodium (PPS), is used to treat interstitial cystitis. Interstitial cystis is an ailment of the urinary tract system that may cause pain in the abdomen, pelvic and genital regions. Although Elmiron is not a cure to interstitial cystitis (IC), it aids in relieving some of the symptoms associated with bladder pain syndrome.

Recent Emiron Cases


Continue Reading Elmiron Litigation Continues: What they still aren’t telling you…

In addition to those previously filed, three new lawsuits have been filed against Teva Pharmaceuticals, the manufacturer of the intrauterine medical device (IUD) known as Paragard.

As we have written before, Paragard is a small plastic T-shaped device with a copper wire coiled around it. Recent lawsuits allege that Paragard is defective and causes serious complications and injuries. The IUD can break off or become dislodged upon removal, causing severe damage to the surrounding tissues and organs.


Continue Reading Paragard IUD Alleged to Cause Serious Injuries

In addition to hundreds of individual suits, the nation-wide litigation against JUUL now includes more than 100 public school districts, across nine states, including Pennsylvania. These school districts are seeking to hold JUUL accountable for its role in fueling the e-cigarette crisis, causing districts to divert valuable taxpayer funding to anti-vaping education, and addressing absences caused by JUUL related sicknesses.

Continue Reading More than 100 School Districts Join Litigation Against JUUL

In the face of mounting nationwide lawsuits and continuing alarming testing data, the United States Food and Drug Administration (FDA) has finally announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. As a result of this immediate market withdrawal request, ranitidine products (commonly known by the brand name Zantac) will not be available for new or existing prescriptions or OTC use in the U.S.

The FDA is also advising consumers taking OTC ranitidine to stop taking any tablets or liquid they currently have, and seek other drugs approved for the same or similar uses as ranitidine that do not carry the same cancer risks.


Continue Reading FDA Zantac Recall: Too Little, Too Late

You have seen a lot of commercials and have probably been searching the internet for some straightforward explanations about Paragard. Here is a simple guide to Paragard lawsuits and settlements in four easy steps:

  • Step 1: Get Your Medical Records Confirming Your IUD Implant.
  • Step 2: Identify Your Paragard IUD Implant.
  • Step 3: Identify Your Related Injury.
  • Step 4: Contact a Paragard Attorney.


Continue Reading A Simple Guide to Paragard Lawsuits and Settlements

So, what is my defective hernia mesh case worth?

It is a very simple question, but you have done quite a bit of research and consulted with supposed experts – and no one can give you a straight answer. The answer is that no one knows specifically what your case is worth right now, that is why there are ongoing nationwide litigations. But before you go back to your Google search, while no one can tell you specifically what your case is worth, we can tell you what attorneys consider when they estimate the potential value of hernia mesh cases.

Here is what you need to consider:

  1. What were the settlement values in similar litigations?
  2. What are the strengths and weaknesses of your individual case?
  3. What can you expect to walk away with?

Helpful hint: If someone does tell you that they know exactly what your hernia mesh case is worth – at best they have no idea what they are talking about; and at worst they are an infomercial trying to sell you something. The same holds true for anyone guaranteeing a favorable outcome. This is litigation and there is always a chance that plaintiffs in litigation lose, making their cases worth nothing.


Continue Reading A Guide to Figuring Out What Your Defective Hernia Mesh Case is Worth

How Do I Know If I Have a Zantac Cancer Claim?

You have already done quite a bit of internet research and likely found that getting to the answer can be a little more complicated than it sounds. “Zantac” is just the brand name of a popular heartburn drug called ranitidine (kind of like Xerox is just the popular brand name of a copy machine). So we will just use the name Zantac to loosely refer to all ranitidine products. Zantac can be prescribed by a doctor or purchased over-the-counter, for different digestive issues. Zantac is produced by a bunch of drug companies you know (Pfizer, GlaxoSmithKline, Sanofi, Boehringer, etc.) and a bunch of generic drug manufacturers that you have probably never heard of. You have also likely been told by now that generic drug companies are generally immune to lawsuits (yes and no – but you likely will have to prove that you were not taking generic Zantac only). In addition, you may have been taking combinations of different types of Zantac over several years, and you obviously did not save all of your Zantac receipts. All of this starts to seem complicated, but you have to break it down into more manageable parts.


Continue Reading A Simple Guide to Zantac Cancer Lawsuits and Settlements

The primary Bard Hernia Mesh state litigation, pending in Rhode Island state court under Judge Gibney, is now set to begin its first bellwether trials that will focus on claims involving the Ventralex patch product, and proceed to trials involving the Composix E/X product. Not to be outdone, and though only designated in August 2018, the Bard Hernia Mesh Multidistrict Litigation (“MDL”) in the United States District Court for the Southern District of Ohio under Judge Sargus, is also steaming along. Plaintiffs and Defendants have narrowed down the initial bellwether pool to six cases – three cases chosen by each side. On January 13, 2020, the parties will submit briefing detailing which cases each party believes should go to trial. Based on that briefing, on January 24, 2020, the Court will select three of those cases for the first bellwether trials. After remaining case specific discovery and motion practice, those cases will go to trial on May 11, 2020; July 13, 2020; and September 14, 2020.

Continue Reading Bard Hernia Mesh Cases Leading the Charge to Settlements in Hernia Mesh Litigations

What is Zantac (ranitidine)?

You have seen a lot of commercials and have probably been searching the internet for some straightforward explanations about Zantac Cancer Lawsuits and Settlements.

Very simply, Zantac is the brand name of a common heartburn medication called ranitidine. Zantac (ranitidine) is a type of drug known as an H2 blocker, or H2 antagonist, which decreases stomach acid by blocking histamine receptors in the stomach. It can be used to treat peptic ulcers, gastroesophageal reflux disease, and related conditions.


Continue Reading What is the Deal With Zantac Cancer Lawsuits and Settlements?

The potential issues with Zantac just became a little more complicated. Zantac is the brand name of a common heartburn medication called ranitidine. As we have reported, there have been multiple, and ongoing, recalls of ranitidine after testing of lots of the drug showed unacceptable levels of the probable human carcinogen N-nitrosodimethylamine (NDMA).

Continue Reading Zantac and Cancer: the Plot Thickens